• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

顽固性高血压与糖尿病、慢性肾脏病以及钠、钙、镁和磷相互作用的相关性分析

Correlational Analysis of Resistant Hypertension with Diabetes Mellitus, Chronic Kidney Disease, and the Interplay of Sodium, Calcium, Magnesium, and Phosphorus.

作者信息

Feng Xin-Di, Wang Shao-Feng, Qiao Si-Yu, Huang Jia-Ying, Ma Zi-Lin, Zhou Duan, Tang Jing-Yi, Wei Yi-Hong

机构信息

Department of Cardiovascular, Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, People's Republic of China.

Department of Traditional Chinese Medicine, Chuansha Huaxia Community Health Service Center, Shanghai, People's Republic of China.

出版信息

Vasc Health Risk Manag. 2025 Apr 7;21:217-228. doi: 10.2147/VHRM.S504454. eCollection 2025.

DOI:10.2147/VHRM.S504454
PMID:40224136
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11992472/
Abstract

OBJECTIVE

To analyze the relationship between resistant hypertension (RH) and hypertension, diabetes mellitus, chronic kidney disease, sodium, calcium, magnesium, phosphorus.

METHODS

A total of 475 patients with hypertension admitted to Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine from January 2021 to December 2023 were divided into hypertension group (HT group) and resistant hypertension group (RH group). We compared the differences between these two groups, and analyzed the influencing factors of RH, as well as the correlation between RH and the course of hypertension, diabetes mellitus, chronic kidney disease, and levels of sodium, calcium, magnesium and phosphorus.

RESULTS

Compared with HT group, RH group had a significantly higher blood pressure ( < 0.05), longer duration of hypertension, diabetes mellitus, and chronic kidney disease ( < 0.01) and a higher proportion of combined chronic kidney disease ( = 0.006). The duration of hypertension, serum sodium ion concentration (≥142.00 mmol/L), calcium ion concentration (2.19 to < 2.30 mmol/L), and 24h urinary phosphorus ion level were independent influencing factors of RH ( < 0.05).

CONCLUSION

For hypertension patients with diabetes mellitus or chronic kidney disease, the risk of RH is significantly higher. The risk of RH may be lower in patients with blood sodium <142.00 mmol/L, blood calcium >2.29 mmol/L, 24h urine sodium and magnesium ions of 116.52 and 2.69 mmol, respectively, and higher 24h urine phosphorus ions.

摘要

目的

分析难治性高血压(RH)与高血压、糖尿病、慢性肾脏病、钠、钙、镁、磷之间的关系。

方法

选取2021年1月至2023年12月上海中医药大学附属龙华医院收治的475例高血压患者,分为高血压组(HT组)和难治性高血压组(RH组)。比较两组之间的差异,分析RH的影响因素,以及RH与高血压病程、糖尿病、慢性肾脏病、钠、钙、镁、磷水平的相关性。

结果

与HT组相比,RH组血压显著更高(<0.05),高血压、糖尿病和慢性肾脏病病程更长(<0.01),合并慢性肾脏病的比例更高(=0.006)。高血压病程、血清钠离子浓度(≥142.00 mmol/L)、钙离子浓度(2.19至<2.30 mmol/L)和24小时尿磷离子水平是RH的独立影响因素(<0.05)。

结论

合并糖尿病或慢性肾脏病的高血压患者发生RH的风险显著更高。血钠<142.00 mmol/L、血钙>2.29 mmol/L、24小时尿钠和镁离子分别为116.52和2.69 mmol且24小时尿磷离子更高的患者发生RH的风险可能更低。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e50/11992472/1b42d19d3aa5/VHRM-21-217-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e50/11992472/7154502c29e6/VHRM-21-217-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e50/11992472/1b42d19d3aa5/VHRM-21-217-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e50/11992472/7154502c29e6/VHRM-21-217-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e50/11992472/1b42d19d3aa5/VHRM-21-217-g0002.jpg

相似文献

1
Correlational Analysis of Resistant Hypertension with Diabetes Mellitus, Chronic Kidney Disease, and the Interplay of Sodium, Calcium, Magnesium, and Phosphorus.顽固性高血压与糖尿病、慢性肾脏病以及钠、钙、镁和磷相互作用的相关性分析
Vasc Health Risk Manag. 2025 Apr 7;21:217-228. doi: 10.2147/VHRM.S504454. eCollection 2025.
2
Resistant and undertreated hypertension in patients with chronic kidney disease: data from the PATRIOTIC survey.慢性肾脏病患者的耐药和治疗不足的高血压:来自 PATRIOTIC 调查的数据。
Clin Exp Hypertens. 2018;40(8):784-791. doi: 10.1080/10641963.2018.1433193. Epub 2018 Mar 6.
3
Renal calcium, phosphorus, magnesium and uric acid handling: comparison between stage III chronic kidney disease patients and healthy oldest old.肾脏钙、磷、镁和尿酸的处理:III 期慢性肾脏病患者与健康高龄老人的比较。
Int Urol Nephrol. 2012 Oct;44(5):1559-62. doi: 10.1007/s11255-012-0230-0. Epub 2012 Aug 15.
4
Resistant Hypertension, Time-Updated Blood Pressure Values and Renal Outcome in Type 2 Diabetes Mellitus.2 型糖尿病患者的耐药性高血压、时间更新的血压值与肾脏结局。
J Am Heart Assoc. 2017 Sep 22;6(9):e006745. doi: 10.1161/JAHA.117.006745.
5
PAIT-Survey Follow-Up: Changes in Albuminuria in Hypertensive Diabetic Patients with Mild-Moderate Chronic Kidney Disease.PAIT调查随访:轻度至中度慢性肾脏病高血压糖尿病患者蛋白尿的变化
High Blood Press Cardiovasc Prev. 2020 Feb;27(1):43-49. doi: 10.1007/s40292-020-00358-1. Epub 2020 Jan 9.
6
24-Hour Urinary Chemistries and Kidney Stone Risk.24 小时尿液化学成分分析与肾结石风险。
Am J Kidney Dis. 2024 Aug;84(2):164-169. doi: 10.1053/j.ajkd.2024.02.010. Epub 2024 Apr 5.
7
Resistant hypertension: do all definitions describe the same patients?难治性高血压:所有定义所描述的患者都相同吗?
J Hum Hypertens. 2015 Sep;29(9):530-4. doi: 10.1038/jhh.2014.128. Epub 2015 Jan 15.
8
Calcium-phosphorus-magnesium homeostasis in pregnant women after renal transplantation.肾移植术后孕妇的钙磷镁稳态
Int J Gynaecol Obstet. 2003 Feb;80(2):111-6. doi: 10.1016/s0020-7292(02)00334-x.
9
Levels of some micronutrients in some Nigerian hypertensives.一些尼日利亚高血压患者体内某些微量营养素的水平。
East Afr J Public Health. 2011 Sep;8(3):212-5.
10
Risk Factor Control in Stroke Survivors with Diagnosed and Undiagnosed Diabetes: A Ghanaian Registry Analysis.中风幸存者中有诊断和未诊断糖尿病患者的危险因素控制:加纳登记分析。
J Stroke Cerebrovasc Dis. 2020 Dec;29(12):105304. doi: 10.1016/j.jstrokecerebrovasdis.2020.105304. Epub 2020 Sep 22.

本文引用的文献

1
Diagnosis and management of resistant hypertension.耐药性高血压的诊断与治疗。
BMJ. 2024 Jun 19;385:e079108. doi: 10.1136/bmj-2023-079108.
2
Pulmonary hypertension and chronic kidney disease: prevalence, pathophysiology and outcomes.肺动脉高压与慢性肾脏病:患病率、病理生理学与转归。
Nat Rev Nephrol. 2024 Nov;20(11):742-754. doi: 10.1038/s41581-024-00857-7. Epub 2024 Jun 18.
3
Prevalence of hypertension among type 2 diabetes mellitus patients in China: a systematic review and meta-analysis.中国 2 型糖尿病患者高血压患病率的系统评价和荟萃分析。
Int Health. 2024 Mar 4;16(2):144-151. doi: 10.1093/inthealth/ihad047.
4
2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension: Endorsed by the International Society of Hypertension (ISH) and the European Renal Association (ERA).2023ESH 动脉高血压管理指南 欧洲高血压学会动脉高血压管理工作组:得到国际高血压学会 (ISH) 和欧洲肾脏协会 (ERA) 的认可。
J Hypertens. 2023 Dec 1;41(12):1874-2071. doi: 10.1097/HJH.0000000000003480. Epub 2023 Sep 26.
5
Temporal trends in prevalence and mortality for chronic kidney disease in China from 1990 to 2019: an analysis of the Global Burden of Disease Study 2019.1990年至2019年中国慢性肾脏病患病率和死亡率的时间趋势:全球疾病负担研究2019分析
Clin Kidney J. 2022 Oct 10;16(2):312-321. doi: 10.1093/ckj/sfac218. eCollection 2023 Feb.
6
Prevalence of Apparent Treatment-Resistant Hypertension in Chronic Kidney Disease in Two Large US Health Care Systems.在美国两大医疗保健系统中慢性肾脏病中明显治疗抵抗性高血压的流行情况。
Clin J Am Soc Nephrol. 2022 Oct;17(10):1457-1466. doi: 10.2215/CJN.04110422. Epub 2022 Sep 9.
7
Heart rate changes and myocardial sodium.心率变化与心肌钠。
Physiol Rep. 2022 Sep;10(17):e15446. doi: 10.14814/phy2.15446.
8
Prevalence, phenotypic characteristics and prognostic role of apparent treatment resistant hypertension in the German Chronic Kidney Disease (GCKD) study.在德国慢性肾脏病(GCKD)研究中,明显治疗抵抗性高血压的流行情况、表型特征和预后作用。
J Hum Hypertens. 2023 May;37(5):345-353. doi: 10.1038/s41371-022-00701-0. Epub 2022 May 9.
9
Retinal Capillary Damage Is Already Evident in Patients With Hypertension and Prediabetes and Associated With HbA1c Levels in the Nondiabetic Range.视网膜毛细血管损伤在高血压和糖尿病前期患者中已经明显存在,并与非糖尿病范围内的 HbA1c 水平相关。
Diabetes Care. 2022 Jun 2;45(6):1472-1475. doi: 10.2337/dc21-1569.
10
Calcium Channels in the Heart: Disease States and Drugs.心脏钙通道:疾病状态与药物。
Cells. 2022 Mar 10;11(6):943. doi: 10.3390/cells11060943.